Oxford Industries: New Promoter, 99% Capital Cut, Auditor and CFO Change

Auditor Resigned MidtermManagement Changes View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-5.0%Reaction day

₹8.85

prior close

₹8.41

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.6%-5.6% vs market

Other Textile Products peers, median of 182sector+0.2%-5.2% vs sector

On the reaction day the stock moved 5.6 pts less than Nifty Microcap 250 and 5.2 pts less than its Other Textile Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-5.0+0.6-5.6+0.2-5.2

Next day

-9.7+0.9-10.7-0.2-9.6

-14.1-0.2-13.9-0.4-13.7

-18.4-0.9-17.5-0.7-17.7

-22.5-0.5-22.0-1.2-21.3

-26.3+0.8-27.1-0.6-25.7

-33.4-0.0-33.4-0.9-32.5

15d

-14.0+3.9-18.0-0.7-13.4

+26.4+4.8+21.6-0.9+27.4

+64.9+5.1+59.7-0.6+65.5

+1.1-1.6+2.8-5.7+6.8

UpDownMarket · Nifty Microcap 250Sector · Other Textile Products peers, median of 182Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved change of promoter: Saroj Kumar Choudhary acquires 46.46 percent stake (27.6 lakh shares), becomes new MD. PAMS and Associates resigned as auditor citing location issues; Lipika and Associates appointed for 5 years. Capital reduction of 99 percent proposed due to accumulated losses. Registered office shifting from Maharashtra to Orissa. MOA amended to add healthcare and pharma business.

Likely market impact

Major ownership change, 99 percent capital cut signals serious financial trouble; business pivot to healthcare and pharma. High risk.